-
[1]
黄欣, 高亚萍, 王希良, 辛忠涛, 董洁, 邵宁生, 柳川, 2006: Screening and Identification of the SARS-CoV N Protein Epitopes, Virologica Sinica, 21, 314-318.
-
[2]
Guo-hui CHANG, Andrew Dividson, Lei LIN, Matt Wilson, Stuart G Siddell, Qing-yu ZHU, 2010: Establishment of the Eukaryotic Cell Lines for Inducible Control of SARS-CoV Nucleocapsid Gene Expression*, Virologica Sinica, 25, 361-368. doi: 10.1007/s12250-010-3124-2
-
[3]
Yi ZHANG, Wei WANG, Jin-rong GAO, Li YE, Xiao-nan FANG, Ying-chun ZENG, Zheng-hui WU, Ying-long SHE, Lin-bai YE, 2007: The Functional Motif of SARS-CoV S Protein Involved in the Interaction with ACE2, Virologica Sinica, 22, 1-7.
-
[4]
Li-li XU, Zhi-hong HU, Hua-lin WANG, Xiao HAN, Fei DENG, 2009: Evaluation of Sensitivities and Specificities of SARS-CoV Detection by Real-time Quantitative Reverse Transcription-PCR Assays*, Virologica Sinica, 24, 187-193. doi: 10.1007/s12250-009-3021-8
-
[5]
Kai Wu, Dehe Wang, Junhao Wang, Yu Zhou, 2022: Translation landscape of SARS-CoV-2 noncanonical subgenomic RNAs, Virologica Sinica, 37, 813-822. doi: 10.1016/j.virs.2022.09.003
-
[6]
冯燕*, 卢亦愚, 严菊英, 史雯, 李敏红, 龚黎明, 葛琼, 周敏, 2005: Real-time Quantitative RT-PCR Assay for Quick Detection of SARS-associated Coronavirus RNA, Virologica Sinica, 20, 228-231.
-
[7]
Zhongyu Zhu, Ponraj Prabakaran, Weizao Chen, Christopher C. Broder, Rui Gong, Dimiter S. Dimitrov, 2013: Human Monoclonal Antibodies as Candidate Therapeutics Against Emerging Viruses and HIV-1, Virologica Sinica, 28, 71-80. doi: 10.1007/s12250-013-3313-x
-
[8]
赵琳, 涂亦娴, 于杨, 金华利, 陈则, 王宾, 2006: Role of ORF7 in the Genome of SARS-CoV, Virologica Sinica, 21, 343-347.
-
[9]
蔡恒玲, 吴移谋, 万艳平, 肖建华, 杨秋林, 曾桥, 赵飞骏, 唐曼娟, 2005: Construction of the Eukariotic Expression Vector for s1 Gene Fragment of SARS-CoV and its Immunol ogical Effects, Virologica Sinica, 20, 464-467.
-
[10]
Zezhong Liu, Shuai Xia, Xinling Wang, Qiaoshuai Lan, Wei Xu, Qian Wang, Shibo Jiang, Lu Lu, 2020: Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection, Virologica Sinica, 35, 340-343. doi: 10.1007/s12250-020-00214-5
-
[11]
Shibo Jiang, Zheng-Li Shi, 2020: The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus, Virologica Sinica, 35, 263-265. doi: 10.1007/s12250-020-00206-5
-
[12]
Lok-Yin Roy Wong, Pak-Yin Lui, Dong-Yan Jin, 2016: A molecular arms race between host innate antiviral response and emerging human coronaviruses, Virologica Sinica, 31, 12-23. doi: 10.1007/s12250-015-3683-3
-
[13]
马翠卿, 周育森, 王弋嘉, 郭彦, 管洁, 魏林, 何玉先, 2005: Expression and Immunogenicity Analysis of the Receptor-binding Region of SARS-CoV Spike Protein, Virologica Sinica, 20, 472-475.
-
[14]
王健伟, 王彦斌, 常昭瑞, 闫克夏, 谭文杰, 屈建国, 夏宁邵, 阮力, 洪涛, 2006: Specificity and Epitope Mapping of Four Monoclonal Antibodies against SARS-CoV Nucleocapsid Protein, Virologica Sinica, 21, 207-212.
-
[15]
何贤辉, 徐丽慧, 蔡小嫦, 曾耀英, , 2004: Construction of an Eukaryotic Expression Vector for SARS-CoV Sars7a and EGFP Fusion Protein Expression, Virologica Sinica, 19, 209-213.
-
[16]
Yuan-peng ZHANG, Rong-wu ZHANG, Wei-shan CHANG, Yan-yan WANG, 2010: Cxcl16 Interact With SARS-CoV N Protein In and Out Cell, Virologica Sinica, 25, 369-374. doi: 10.1007/s12250-010-3129-x
-
[17]
Mengyuan Chen, Shuizhen He, Hualong Xiong, Dongxu Zhang, Shaojuan Wang, Wangheng Hou, Xiaomei Zhu, Jin Wang, Yang Huang, Congming Hong, Yubin Wu, Ruoyao Qi, Tianying Zhang, Quan Yuan, Tingdong Li, Yixin Chen, Shiyin Zhang, Shengxiang Ge, Jun Zhang, Ningshao Xia, 2022: New discovery of high-affinity SARS-CoV-2 spike S2 protein binding peptide selected by PhIP-Seq, Virologica Sinica, 37, 758-761. doi: 10.1016/j.virs.2022.07.001
-
[18]
Jiang-Fan Li, Lei He, Yong-Qiang Deng, Shu-Hui Qi, Yue-Hong Chen, Xiao-Lu Zhang, Shi-Xiong Hu, Rui-Wen Fan, Guang-Yu Zhao, Cheng-Feng Qin, 2021: Generation and Characterization of a Nanobody Against SARS-CoV, Virologica Sinica, 36, 1484-1491. doi: 10.1007/s12250-021-00436-1
-
[19]
Ke Wang, Yu Pan, Dianbing Wang, Ye Yuan, Min Li, Yuanyuan Chen, Lijun Bi, Xian-En Zhang, 2023: Altered hACE2 binding affinity and S1/S2 cleavage efficiency of SARS-CoV-2 spike protein mutants affect viral cell entry, Virologica Sinica, 38, 595-605. doi: 10.1016/j.virs.2023.06.005
-
[20]
Ashutosh Singh, Rahul Soloman Singh, Phulen Sarma, Gitika Batra, Rupa Joshi, Hardeep Kaur, Amit Raj Sharma, Ajay Prakash, Bikash Medhi, 2020: A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV, Virologica Sinica, 35, 290-304. doi: 10.1007/s12250-020-00252-z